Citigroup’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,231
| Closed | -$63K | – | 6908 |
|
|
2022
Q1 | $63K | Sell |
2,231
-103,990
| -98% | -$2.85M | ﹤0.01% | 4630 |
|
|
2021
Q4 | $2.9M | Sell |
106,221
-241,922
| -69% | -$6.56M | ﹤0.01% | 2302 |
|
|
2021
Q3 | $9.47M | Buy |
348,143
+334,492
| +2,450% | +$8.27M | 0.01% | 1449 |
|
|
2021
Q2 | $233K | Sell |
13,651
-719
| -5% | -$13.5K | ﹤0.01% | 4168 |
|
|
2021
Q1 | $299K | Sell |
14,370
-8,953
| -38% | -$207K | ﹤0.01% | 3786 |
|
|
2020
Q4 | $534K | Buy |
23,323
+2,049
| +10% | +$39K | ﹤0.01% | 4150 |
|
|
2020
Q3 | $347K | Sell |
21,274
-21,238
| -50% | -$385K | ﹤0.01% | 4170 |
|
|
2020
Q2 | $576K | Buy |
42,512
+1,715
| +4% | +$20K | ﹤0.01% | 4109 |
|
|
2020
Q1 | $484K | Buy |
40,797
+33,913
| +493% | +$752K | ﹤0.01% | 3900 |
|
|
2019
Q4 | $172K | Buy |
6,884
+1,394
| +25% | +$28.2K | ﹤0.01% | 5314 |
|
|
2019
Q3 | $94K | Sell |
5,490
-9,456
| -63% | -$172K | ﹤0.01% | 5719 |
|
|
2019
Q2 | $340K | Buy |
14,946
+1,433
| +11% | +$38.6K | ﹤0.01% | 4811 |
|
|
2019
Q1 | $435K | Sell |
13,513
-62,933
| -82% | -$1.95M | ﹤0.01% | 4337 |
|
|
2018
Q4 | $2.15M | Sell |
76,446
-62,980
| -45% | -$1.84M | ﹤0.01% | 2595 |
|
|
2018
Q3 | $4.01M | Buy |
139,426
+54,532
| +64% | +$1.64M | ﹤0.01% | 2087 |
|
|
2018
Q2 | $3.18M | Sell |
84,894
-47,634
| -36% | -$1.87M | ﹤0.01% | 2258 |
|
|
2018
Q1 | $5.21M | Sell |
132,528
-98,677
| -43% | -$3.6M | ﹤0.01% | 1714 |
|
|
2017
Q4 | $7.49M | Buy |
231,205
+59,528
| +35% | +$1.79M | 0.01% | 1491 |
|
|
2017
Q3 | $5.35M | Buy |
171,677
+70,406
| +70% | +$2.08M | ﹤0.01% | 1704 |
|
|
2017
Q2 | $2.83M | Buy |
101,271
+100,193
| +9,294% | +$2.27M | ﹤0.01% | 2223 |
|
|
2017
Q1 | $18K | Sell |
1,078
-24,989
| -96% | -$350K | ﹤0.01% | 6318 |
|
|
2016
Q4 | $315K | Buy |
26,067
+23,425
| +887% | +$303K | ﹤0.01% | 4875 |
|
|
2016
Q3 | $41K | Sell |
2,642
-444
| -14% | -$6.69K | ﹤0.01% | 5802 |
|
|
2016
Q2 | $40K | Sell |
3,086
-14,169
| -82% | -$222K | ﹤0.01% | 5717 |
|
|
2016
Q1 | $328K | Buy |
17,255
+9,669
| +127% | +$175K | ﹤0.01% | 4605 |
|
|
2015
Q4 | $171K | Buy |
7,586
+6,945
| +1,083% | +$137K | ﹤0.01% | 4891 |
|
|
2015
Q3 | $15K | Sell |
641
-1,605
| -71% | -$44.3K | ﹤0.01% | 6222 |
|
|
2015
Q2 | $64K | Sell |
2,246
-1,711
| -43% | -$44.8K | ﹤0.01% | 5345 |
|
|
2015
Q1 | $102K | Sell |
3,957
-23,638
| -86% | -$541K | ﹤0.01% | 5016 |
|
|
2014
Q4 | $512K | Buy |
27,595
+27,391
| +13,427% | +$493K | ﹤0.01% | 3866 |
|
|
2014
Q3 | $3K | Buy |
+204
| New | +$3.07K | ﹤0.01% | 6753 |
|
Citigroup's XENT Position: Q2 2022 in Review
Citigroup sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 2,231 shares — an estimated $63K sold.
Citigroup first reported a position in XENT in Q3 2014 and held it in 31 quarters. The position peaked at $9.47M in Q3 2021. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Citigroup reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Citigroup sold 2,231 Intersect ENT, Inc shares in Q2 2022, an estimated $63K.
- Citigroup first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 31 quarters.
- Citigroup's Intersect ENT, Inc position peaked at $9.47M in Q3 2021.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.